Actively Recruiting

Phase Not Applicable
Age: 18Years - 88Years
MALE
NCT06224218

Prostate Single Port & Laser Enucleation Comparison Trial

Led by University of Illinois at Chicago · Updated on 2024-05-16

116

Participants Needed

1

Research Sites

186 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Surgical treatments for benign prostatic hyperplasia (BPH) are necessary when non-procedural approaches fail to alleviate lower urinary tract symptoms (LUTS) or bladder outlet obstruction (BOO). Open simple prostatectomy and laser enucleation are recommended for prostatic adenoma size greater than 80 ml. Minimally invasive approaches, such as robotic-assisted simple prostatectomy, have gained popularity due to their comparable outcomes with lower morbidity. The introduction of the da Vinci single-port (SP) robotic platform offers potential advantages, but its outcomes have not been thoroughly investigated. This randomized controlled trial aims to compare the outcomes of SP simple prostatectomy performed using the da Vinci robotic platform versus thulium laser enucleation of the prostate for the treatment of BPH and BOO.

CONDITIONS

Official Title

Prostate Single Port & Laser Enucleation Comparison Trial

Who Can Participate

Age: 18Years - 88Years
MALE

Eligibility Criteria

Eligible

You may qualify if you...

  • Patients diagnosed with symptomatic Benign Prostatic Hyperplasia (BPH) who fail conservative treatment with drug therapy are eligible for surgical intervention.
Not Eligible

You will not qualify if you...

  • Adults unable to consent
  • Prisoners
  • Cognitive impaired adults
  • Coagulopathy

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

UI Health SCB Clinic Department of Urology

Chicago, Illinois, United States, 60612

Actively Recruiting

Loading map...

Research Team

R

Ruben Sauer, MD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here